Cargando…

Handling the Hurdles on the Way to Anti-tuberculosis Drug Development

The global epidemic of tuberculosis (TB) imposes a sustained epidemiologic vigilance and investments in research by governments. Mycobacterium tuberculosis, the main causative agent of TB in human beings, is a very successful pathogen, being the main cause of death in the population among infectious...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dalberto, Pedro F., de Souza, Eduardo V., Abbadi, Bruno L., Neves, Christiano E., Rambo, Raoní S., Ramos, Alessandro S., Macchi, Fernanda S., Machado, Pablo, Bizarro, Cristiano V., Basso, Luiz A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710551/ https://www.ncbi.nlm.nih.gov/pubmed/33330374 http://dx.doi.org/10.3389/fchem.2020.586294

Ejemplares similares

Synthesis and Antimycobacterial Activity of 3-Phenyl-1H-indoles
por: Jardim Etchart, Renata, et al.
Publicado: (2021)

8-Mercaptoguanine-based inhibitors of Mycobacterium tuberculosis dihydroneopterin aldolase: synthesis, in vitro inhibition and docking studies
por: Czeczot, Alexia de Matos, et al.
Publicado: (2021)

Ultrasound-Assisted Synthesis of 4-Alkoxy-2-methylquinolines: An Efficient Method toward Antitubercular Drug Candidates
por: Borsoi, Ana Flávia, et al.
Publicado: (2021)

EPSP Synthase-Depleted Cells Are Aromatic Amino Acid Auxotrophs in Mycobacterium smegmatis
por: Duque-Villegas, Mario Alejandro, et al.
Publicado: (2021)

Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments
por: Freitas de Freitas, Talita, et al.
Publicado: (2022)

Synthesis and Antimycobacterial Evaluation of N-(4-(Benzyloxy)benzyl)-4-aminoquinolines
por: Grams, Estevão Silveira, et al.
Publicado: (2022)

Evaluation of 3-Deoxy-D-Arabino-Heptulosonate 7-Phosphate Synthase (DAHPS) as a Vulnerable Target in Mycobacterium tuberculosis
por: Galina, Luiza, et al.
Publicado: (2022)

Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in Mycobacterium tuberculosis?
por: Abbadi, Bruno L., et al.
Publicado: (2018)

Mycobacterium tuberculosis Shikimate Pathway Enzymes as Targets for the Rational Design of Anti-Tuberculosis Drugs
por: Nunes, José E. S., et al.
Publicado: (2020)

Bacterial Enoyl-Reductases: The Ever-Growing List of Fabs, Their Mechanisms and Inhibition
por: Hopf, Fernanda S. M., et al.
Publicado: (2022)

SARS-CoV-2 immune complex triggers human monocyte necroptosis
por: Santos, Leonardo Duarte, et al.
Publicado: (2023)

Computational Enzyme Design: Advances, hurdles and possible ways forward
por: Linder, Mats
Publicado: (2012)

Maternal and neonatal immunization in the Americas: The benefits, the hurdles, and the way forward()
por: Pasetti, Marcela F., et al.
Publicado: (2021)

Observed crowding effects on Mycobacterium tuberculosis 2-trans-enoyl-ACP (CoA) reductase enzyme activity are not due to excluded volume only
por: Rotta, Mariane, et al.
Publicado: (2017)

Wild-Type Phosphoribosylpyrophosphate Synthase (PRS) from Mycobacterium tuberculosis: A Bacterial Class II PRS?
por: Breda, Ardala, et al.
Publicado: (2012)

Handling tRNA introns, archaeal way and eukaryotic way
por: Yoshihisa, Tohru
Publicado: (2014)

Which Future for Neuroscience in Forensic Psychiatry: Theoretical Hurdles and Empirical Chances
por: Casartelli, Luca, et al.
Publicado: (2013)

Do Different Hurdle Heights Alter Important Spatiotemporal Variables in Hurdle Clearance?
por: Ozaki, Yusuke, et al.
Publicado: (2022)

IMMU-11. PRECLINICAL HIGH-RISK PEDIATRIC BRAIN TUMOR MODELS FOR IMMUNOTHERAPY: HURDLES AND THE WAY FORWARD
por: Mishra, Deepak, et al.
Publicado: (2023)

Anti-tubercular profile of new selenium-menadione conjugates against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain and multidrug-resistant clinical isolates
por: Ribeiro, Ruan C.B., et al.
Publicado: (2021)

Bridging the gaps to overcome major hurdles in the development of next-generation tuberculosis vaccines
por: Kim, Hongmin, et al.
Publicado: (2023)

Gene replacement and quantitative mass spectrometry approaches validate guanosine monophosphate synthetase as essential for Mycobacterium tuberculosis growth
por: Villela, Anne Drumond, et al.
Publicado: (2015)

Humans in space: the psychological hurdles
por: Kanas, Nick
Publicado: (2015)

New hurdles for translational research
por: Dowsett, Mitch
Publicado: (2000)

Hurdles of publication: to authors to overcome
por: Mohammadhassanzadeh, Hafez, et al.
Publicado: (2014)

Hurdles to Cardioprotection in the Critically Ill
por: See Hoe, Louise E, et al.
Publicado: (2019)

Hurdles in Basic Science Translation
por: Perry, Christina J., et al.
Publicado: (2017)

Promises and Hurdles of Medical Tourism Development in the Russian Federation
por: Daykhes, Arkady N., et al.
Publicado: (2020)

Construction of Mycobacterium tuberculosis cdd knockout and evaluation of invasion and growth in macrophages
por: Villela, Anne Drumond, et al.
Publicado: (2017)

Unraveling COVID-19 investigation hurdles with viral genomics
por: Sá, R, et al.
Publicado: (2023)

Kinematic Factors Associated with Hitting Hurdles During the Initial Phase of a 110-m Hurdle Race
por: Iwasaki, Ryo, et al.
Publicado: (2022)

Tuberculosis septic shock, an elusive pathophysiology and hurdles in management: A case report and review of literature
por: Mishra, Rashmi, et al.
Publicado: (2019)

Defining the critical hurdles in cancer immunotherapy
por: Fox, Bernard A, et al.
Publicado: (2011)

Immunotherapy for Alzheimer’s disease: hoops and hurdles
por: Lemere, Cynthia A
Publicado: (2013)

Antimicrobial shortages: Another hurdle for clinicians
por: Valiquette, Louis, et al.
Publicado: (2015)

Artificial insemination history: hurdles and milestones
por: Ombelet, W., et al.
Publicado: (2015)

Ethical Hurdles in the Prioritization of Oncology Care
por: de Groot, Folkert, et al.
Publicado: (2016)

Identifying and hurdling obstacles to translational research
por: Sabroe, Ian, et al.
Publicado: (2007)

Interchangeability of Biosimilars: Overcoming the Final Hurdles
por: Barbier, Liese, et al.
Publicado: (2021)

Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
por: Sarantis, Panagiotis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i5qm1mgnvauamrahc1tajc4asn